Related Experiment Video
Updated: Sep 9, 2025

07:08
A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
Published on: April 6, 2021
5.1K
A Rapid and Modular Nanobody Assay for Plug-and-Play Antigen Detection
N Rebecca Kang1,2, Jisoo Im1,2, John R Biondo3,4
1Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.
ACS Synthetic Biology
|September 3, 2025
Summary
A new Rapid and Modular Nanobody Assay (RAMONA) offers fast, portable, and adaptable antigen detection. This versatile platform overcomes limitations of traditional assays for improved diagnostics in diverse settings.
Area of Science:
- Biotechnology
- Immunodiagnostics
- Molecular Biology
Background:
- Current antigen detection methods like ELISA are sensitive but not portable, while portable lateral flow assays (LFAs) lack adaptability for new targets.
- Traditional diagnostic platforms face challenges in low-resource settings due to complex infrastructure, high costs, and long development times.
Purpose of the Study:
- To develop a versatile, rapid, and portable antigen detection platform overcoming limitations of existing diagnostic tools.
- To create a modular assay adaptable for diverse targets and compatible with on-demand biomanufacturing.
Main Methods:
- Developed the Rapid and Modular Nanobody Assay (RAMONA) using nanobody-coiled coil fusion proteins for modular integration.
- Demonstrated assay generalizability by detecting three distinct protein targets and assessing robustness across temperatures and incubation times.
- Validated compatibility with saliva samples and cell-free protein synthesis systems, enabling multiplexed detection.
Main Results:
- RAMONA achieved detection in under 30 minutes with results strongly correlating to Enzyme-Linked Immunosorbent Assay (ELISA) data.
- The assay demonstrated robustness and compatibility with various sample types and conditions, requiring minimal resources.
- Successful multiplexed detection of three antigens was achieved using orthogonal capture probes.
Conclusions:
- RAMONA offers a significant advancement in rapid, adaptable, and field-deployable antigen detection.
- The platform overcomes limitations of traditional immunoassays, enabling on-demand biomanufacturing and rapid adaptation for diverse targets.
- RAMONA provides a versatile solution for point-of-need diagnostics in various settings.

